Publication | Closed Access

Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial

VaccinationVaccine SafetyVaccinologyVaccine DevelopmentImmunologyVirologyMedicineVaccine ResearchActive-controlled Phase 2